(Q27851658)

English

EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

PubMed publication ID

13 November 2016

EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target (English)

1 reference

PubMed publication ID

13 November 2016

cervical squamous cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

K Iida

1

0 references

K Nakayama

2

0 references

M T Rahman

3

0 references

M Rahman

4

0 references

M Ishikawa

5

0 references

A Katagiri

6

0 references

S Yeasmin

7

0 references

Y Otsuki

8

0 references

H Kobayashi

9

0 references

S Nakayama

10

0 references

K Miyazaki

11

0 references

language of work or name

0 references

publication date

26 July 2011

0 references

British Journal of Cancer

0 references

105

0 references

3

0 references

420-7

0 references

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

20 March 2017

The causal relation between human papillomavirus and cervical cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

20 March 2017

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

20 March 2017

Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

20 March 2017

ERBB receptors and cancer: the complexity of targeted inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

7 April 2017

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

7 April 2017

Absence of epidermal growth factor receptor mutations in cervical cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

29 September 2017

Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: implications for Cetuximab-mediated therapy in recurrent/metastatic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

29 September 2017

Development and clinical indications of cetuximab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

29 September 2017

Epidermal growth factor receptor inhibitors in the treatment of non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

29 September 2017

Critical update and emerging trends in epidermal growth factor receptor targeting in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

29 September 2017

Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

29 September 2017

Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

29 September 2017

Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

29 September 2017

Cancer in the developing world: a call to action.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

29 September 2017

Oncogene amplification in solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

29 September 2017

Prognostic value of epidermal growth factor receptor expression in cervical carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

29 September 2017

Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

2 June 2018

EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.222

21 January 2018

Changes in cervical cancer incidence after three decades of screening US women less than 30 years old

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.222

21 January 2018

Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.222

21 January 2018

Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.222

21 January 2018

Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of egfr amplifications despite protein overexpression in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.222

21 January 2018

Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.222

21 January 2018

Comprehensive allelotype study of ovarian tumors of low malignant potential: potential differences in pathways between tumors with and without genetic predisposition to invasive carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.222

21 January 2018

Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status.

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.222

21 January 2018

Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.222

21 January 2018

Epidermal growth factor receptor expression status in lung cancer correlates with its mutation

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.222

21 January 2018

Expression of epidermal growth factor receptor in gastric carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.222

21 January 2018

HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.222

21 January 2018

Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172895

27 November 2018

[Medical treatment of metastatic or recurrent cancer of the cervix]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal expression of epidermal growth factor receptor and c-erbB2 in squamous cell carcinoma of the cervix: correlation with human papillomavirus and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cervical and vulva cancer: changes in FIGO definitions of staging

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic relevance of gene amplifications and coamplifications in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.2011.222

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27851658&oldid=2175350384"